Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Toyo-oka, K.
Right arrow Articles by Wynshaw-Boris, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Toyo-oka, K.
Right arrow Articles by Wynshaw-Boris, A.
[Cancer Research 66, 5565-5573, June 1, 2006]
© 2006 American Association for Cancer Research


Molecular Biology, Pathobiology, and Genetics

Mnt-Deficient Mammary Glands Exhibit Impaired Involution and Tumors with Characteristics of Myc Overexpression

Kazuhito Toyo-oka1, Timothy J. Bowen1, Shinji Hirotsune7, Zirong Li2,3, Sonia Jain4, Sara Ota8, Laure Escoubet Lozach2, Ivan Garcia Bassett5, Jean Lozach2, Michael G. Rosenfeld5,6, Christopher K. Glass8, Robert Eisenman9, Bing Ren2,3, Peter Hurlin8 and Anthony Wynshaw-Boris1

1 Departments of Pediatrics and Medicine, University of California, San Diego Comprehensive Cancer Center; 2 Department of Cellular and Molecular Medicine, Ludwig Cancer Institute; 3 Ludwig Cancer Institute; 4 Department of Family and Preventive Medicine, Division of Biostatistics and Bioinformatics; 5 Department of Medicine; and 6 Howard Hughes Medical Institute, University of California, San Diego School of Medicine, La Jolla, California; 7 Division of Genetic Disease Research, Graduate School of Medicine, Osaka City University, Abeno, Osaka, Japan; 8 Department of Cell and Developmental Biology, Shriners Hospitals for Children, Oregon Health Sciences University, Portland, Oregon; and 9 Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington

Requests for reprints: Anthony Wynshaw-Boris, Departments of Pediatrics and Medicine, University of California, San Diego, Medical Teaching Facility, Room 253, 9500 Gilman Drive, MC 0627, La Jolla, CA 92093-0627. Phone: 858-822-3400; Fax: 858-822-3409; E-mail: awynshawboris{at}ucsd.edu.

The proto-oncogene c-Myc plays a central role in cell growth and the development of human tumors. c-Myc interacts with Max and Myc-Max complexes bind to E-box and related sequences to activate transcription. Max also interacts with Mnt but Mnt-Max complexes repress transcription when bound to these sequences. MNT maps to human chromosome 17p13.3, a region frequently deleted in various human tumors, including mammary gland tumors. Consistent with the possibility that Mnt functions as a Myc antagonist, Mnt-deficient fibroblasts exhibit many of the hallmark characteristics of cells that overexpress Myc, and conditional (Cre/Lox) inactivation of Mnt in mammary gland epithelium leads to adenocarcinomas. Here, we further characterize mammary gland tissue following conditional deletion of Mnt in the mammary gland. We show that loss of Mnt severely disrupts mammary gland involution and leads to hyperplastic ducts associated with reduced numbers of apoptotic cells. These findings suggest that loss of Mnt in mammary tissue has similarities to Myc overexpression. We tested this directly by using promoter array analysis and mRNA expression analysis by oligonucleotide arrays. We found that Mnt and c-Myc bound to similar promoters in tumors from MMTV-c-Myc transgenic mice, and mRNA expression patterns were similar between mammary tumors from MMTV-Cre/MntKO/CKO and MMTV-c-Myc transgenic mice. These results reveal an important role for Mnt in pregnancy-associated mammary gland development and suggest that mammary gland tumorigenesis in the absence of Mnt is analogous to that caused by Myc deregulation. (Cancer Res 2006; 66(11): 5565-73)




This article has been cited by other articles:


Home page
Cancer Res.Home page
Mnt Is a Tumor Suppressor in Mammary Gland
Cancer Res., July 1, 2006; 66(13): 6894 - 6894.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.